Research Articles Library

Search tips: Keywords PMID Journal DOI or use Advanced Search for precise filtering
Literature Analysis Tools
Advanced Search

Filter by PMID, year, source, DOI and other criteria

Literature Analysis

Analyze research trends and hotspots

Batch Export

Export search results to Excel/PDF

Incidence, Disease Burden, and Clinical Presentation of Patients Newly Diagnosed With Inflammatory Bowel Disease in a Population-Based Inception Cohort

Publication Year: 2025 Source: J Crohns Colitis PMID: 39565294 DOI: 10.1093/ecco-jcc/jjae176

BACKGROUND AND AIMS: Emerging data indicate a stabilizing incidence of inflammatory bowel diseases (IBD), including ulcerative colitis (UC), Crohn's disease (CD), and IBD unclassified (IBDU) in Western countries. We aimed to investigate the incidence of IBD, its initial clinical presentation, and patient-reported burden. METHODS: Copenhagen IBD Inception Cohort is a …

Partial Enteral Nutrition in the Management of Crohn's Disease: A Systematic Review and Meta-Analysis

Publication Year: 2025 Source: J Crohns Colitis PMID: 39565924

BACKGROUND: Exclusive enteral nutrition is an established treatment for active Crohn's disease but the role of partial enteral nutrition (PEN) in the broader management of the disease is less clear. This systematic review and meta-analysis reviewed the literature on the role of PEN in Crohn's disease management. METHODS: This review …

The malic acid inhibiting inflammation in ankylosing spondylitis by interfering M1 macrophage polarization

Publication Year: 2025 Source: Int Immunopharmacol PMID: 39566386 DOI: 10.1016/j.intimp.2024.113653

Ankylosing spondylitis (AS) is a motor system immune disease with significant genetic characteristics, resulting in joint fusion, deformity, rigidity, seriously affecting the quality of life of patients. Inflammatory bowel disease (IBD), characterized by intestinal mucosal damage and inflammatory changes, the most common extra-articular manifestation of AS. Due to the limitations …

Intestinal Ultrasound in Common Gastrointestinal Disorders: An Evidence-Based Approach

Publication Year: 2025 Source: Med Clin North Am PMID: 39567092

No Abstract

The improvement of a refractory enterocutaneous fistula with colchicine in a patient with Crohn's disease who had an MEFV gene mutation

Publication Year: 2025 Source: Clin J Gastroenterol PMID: 39567438

No Abstract

PANoptosis-related genes: Molecular insights into immune dysregulation in ulcerative colitis

Publication Year: 2025 Source: J Gastroenterol Hepatol PMID: 39568189

No Abstract

Heat-killed Lacticaseibacillus paracasei 6235 is more effective than live on DSS-induced colitis via modulation of intestinal microbiota and MAPK/NF-κB signaling pathways

Publication Year: 2025 Source: Food Funct PMID: 39569739

This study compared the protective effects of both live Lacticaseibacillus paracasei 6235 (LLP 6235) and heat-killed Lacticaseibacillus paracasei 6235 (HK-LP 6235) on ulcerative colitis. Using a dextran sulfate sodium (DSS)-induced colitis mouse model, we evaluated physiological state, colon tissue integrity, inflammatory factors, tight junction (TJ) proteins, and intestinal microbiota variations. …

Development of Time-Aggregated Machine Learning Model for Relapse Prediction in Pediatric Crohn's Disease

Publication Year: 2025 Source: Clin Transl Gastroenterol PMID: 39569890

INTRODUCTION: Pediatric Crohn's disease (CD) easily progresses to an active disease compared with adult CD, making it important to predict and minimize CD relapses. However, prediction of relapse at various time points (TPs) during pediatric CD remains understudied. We aimed to develop a real-time aggregated model to predict pediatric CD …

Impact of HLADQA1*05 and HLADQA1*03 on Safety and Loss of Response to Anti-Tumor Necrosis Factor in Patients With Inflammatory Bowel Disease

Publication Year: 2025 Source: J Crohns Colitis PMID: 39570188

BACKGROUND: HLADQA1*05 is recently associated with heightened immunogenicity to anti-tumor necrosis factor (TNFalpha). We aimed to determine whether HLADQ1*05 is a risk factor for primary non-response, loss of response (LOR), or adverse events (AE) to first-line anti-TNFalpha in patients with inflammatory bowel disease. METHODS: We performed a retrospective observational study …

Metabolomics combined with network pharmacology revealed a paradigm for determining the mechanism underlying the metabolic action of Gegen Qinlian Decoction amelioration of ulcerative colitis in mice

Publication Year: 2025 Source: J Chromatogr B Analyt Technol Biomed Life Sci PMID: 39571215

No Abstract

98453 Results
Page of
9846 Pages
Need more literature?

The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.

Knowledge Acquisition Module: Upload and analyze your own literature files
External Resources: Access comprehensive literature databases worldwide